PMID- 10822054 OWN - NLM STAT- MEDLINE DCOM- 20000801 LR - 20190624 IS - 0014-2999 (Print) IS - 0014-2999 (Linking) VI - 396 IP - 1 DP - 2000 May 12 TI - 5'-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist. PG - 49-52 AB - 5'-Guanidinonaltrindole (GNTI) possesses 5-fold greater opioid antagonist potency (K(e)=0.04 nM) and an order of magnitude greater selectivity (selectivity ratios >500) than the prototypical kappa-opioid receptor antagonist, norbinaltorphimine, in smooth muscle preparations. Binding and functional studies conducted on cloned human opioid receptors expressed in Chinese hamster ovarian (CHO) cells afforded pA(2) values that were comparable to the smooth muscle data. In view of the high selectivity and potency of GNTI, it is a potentially valuable pharmacological tool for opioid research. FAU - Jones, R M AU - Jones RM AD - Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, 308 Harvard Street S.E., Minneapolis, MN 55455, USA. FAU - Portoghese, P S AU - Portoghese PS LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (17-cyclopropylmethyl-6,7-didehydro-4,5-epoxy-5'-guanidinyl-3,14-dihydroxyindolo(2',3'-6,7)morphinan) RN - 0 (Guanidines) RN - 0 (Ligands) RN - 0 (Morphinans) RN - 0 (Receptors, Opioid, kappa) RN - 100929-53-1 (Enkephalin, Ala(2)-MePhe(4)-Gly(5)-) RN - 5S6W795CQM (Naltrexone) RN - 88373-73-3 (Enkephalin, D-Penicillamine (2,5)-) SB - IM MH - Animals MH - CHO Cells MH - Cricetinae MH - Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology MH - Enkephalin, D-Penicillamine (2,5)-/pharmacology MH - Guanidines MH - Guinea Pigs MH - Humans MH - In Vitro Techniques MH - Ligands MH - Male MH - Membranes/drug effects/metabolism MH - Mice MH - Mice, Inbred ICR MH - Morphinans MH - Muscle, Smooth/drug effects MH - Naltrexone/*analogs & derivatives/pharmacology MH - Receptors, Opioid, kappa/agonists/*antagonists & inhibitors EDAT- 2000/05/24 09:00 MHDA- 2000/08/06 11:00 CRDT- 2000/05/24 09:00 PHST- 2000/05/24 09:00 [pubmed] PHST- 2000/08/06 11:00 [medline] PHST- 2000/05/24 09:00 [entrez] AID - S0014-2999(00)00208-9 [pii] AID - 10.1016/s0014-2999(00)00208-9 [doi] PST - ppublish SO - Eur J Pharmacol. 2000 May 12;396(1):49-52. doi: 10.1016/s0014-2999(00)00208-9.